openPR Logo
Press release

AIDS related Kaposi’s Sarcoma Market Projected to Grow at Steady Rate through 2025

01-17-2018 08:42 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
AIDS related Kaposi’s Sarcoma Market Projected to Grow

AIDS-related Kaposi’s sarcoma is a type of cancer affecting the cells lining, the blood vessels, or lymph nodes. The cancer usually occurs as tumors on skin or mucosal surfaces. It is characterized by brown, red, or purple tumors on the affected area generally called as lesions. The major factors playing the role in the pathogenesis of the cancer are Kaposi’s sarcoma herpes virus/human herpes virus type 8 (KSHV/HHV-8), altered responses to cytokines, and stimulation of Kaposi’s sarcoma growth by HIV-1 trans-activating protein. It is primarily caused by weak immune system due to HIV infection. The cancer can occur on several parts of the body at the same time. It is common among HIV-positive gay or bisexual men, women who were infected with HIV through sex with bisexual men, and people from communities of Africa. It has eight times higher incidence rate in men than women. The incidence rate of AIDS-related KS has decreased over a period of time due to high awareness about sexually transmitted diseases and use of safety methods. This decrease was accelerated after the introduction of highly active antiretroviral therapy (HAART) and immunotherapies.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/aids-related-kaposis-sarcoma-market.html

The AIDS-related Kaposi’s sarcoma market can be segmented by type of therapy and region. Based on type of therapy, the market can be classified as HAART; local therapies such as radiation therapy, cryotherapy, laser therapy, surgical excision, topical retinoids, and intralesional vinca alkaloid therapy; immunomodulation; and cytotoxic agents such as liposomal doxorubicin (Doxil), liposomal daunorubicin (DaunoXome), Paclitaxel, and oral etoposide (VePesid). Currently, liposomal therapy has shown a significant response due to reduced cardiac toxicity and mylotoxicity, previously reported for doxorubicin and daunorubicin. Liposomal doxorubicin is considered as the first line standard for the treatment of this type of cancer. When combined with HAART, the effectiveness of liposomal doxorubicin is enhanced. Chemotherapy is a highly preferred treatment though it is costly. However, high cost of the therapy is likely to be a restraining factor in some developing and underdeveloped countries. The relation of Kaposi’s sarcoma with AIDS is projected to boost the growth of the antiretroviral therapy market. Interferon Alfa (Intron A) is a highly used drug in the class of immunotherapy agents. The demand for radiation therapy is increasing to get better physical appearance of the patient. Intralesional therapy with vinca alkaloids has limited use where localized skin lesions are observed.

The market for AIDS-related Kaposi’s sarcoma has a large opportunity for development in the near future with the discovery of novel drugs by researchers worldwide. For instance, angiogenesis plays an important role in the development of Kaposi’s sarcoma tumors. Angiogenesis inhibitors are currently being developed and are expected to be a promising therapy for the treatment of the disease in the next few years. The research undergoing at IrsiCaixa Aids Research Institute in Barcelona has increased hopes for complete removal of the virus from the blood. The medication is a combination of two HIV vaccines with anticancer drugs. Targeted therapies such as monoclonal antibodies are under clinical trials which are projected to dominate the market in the near future.

Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26111

Geographically, the global market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Among these regions, North America is dominating the market despite having lower number of incidence cases reported. This is attributed to the availability of advance therapies, high rate of diagnosis conditions, and anticipated potential to afford the high cost associated with the treatment. In Africa, the incidence of AIDS-related Kaposi’s sarcoma is significantly high. In the next few years, the market is expected to grow in Middle East & Africa owing to increased prevalence of the disease. Increasing number of regional vendor entries in the market is likely to be observed owing to patent expirations of several blockbuster drugs. Leading companies have opportunities to develop new chemotherapy agents with reduced side effects. Key players operating in this market are Eli Lilly and Co., Bristol-Myers Squibb, Hoffmann-La Roche Inc., Johnson & Johnson, Merck & Co., Inc., Pfizer, Inc., and GlaxoSmithKline plc

Purchase this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=26111<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AIDS related Kaposi’s Sarcoma Market Projected to Grow at Steady Rate through 2025 here

News-ID: 903790 • Views: 146

More Releases from Transparency Market Research

Tunnel Boring Machine Market Demand, Insights and Forecast up to 2025
Overview TMR’s report on the Tunnel Boring Machine Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Tunnel Boring Machine serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Tunnel Boring Machine over the
Cellulose Diacetate Films Market Size to Expand Significantly by the End of 2025
Overview TMR’s report on the Cellulose Diacetate Films Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Cellulose Diacetate Films serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Cellulose Diacetate Films over the
Ruthenium Market Projected to Gain Significant Value by 2025
Overview TMR’s report on the Ruthenium Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Ruthenium serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Ruthenium over the forecast period. These indicators help businesses
Pultrusion Market to Reap Excessive Revenues by 2025
Overview TMR’s report on the Pultrusion Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Pultrusion serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Pultrusion over the forecast period. These indicators help businesses

All 5 Releases


More Releases for Kaposi’s

Kaposi’s Sarcoma Market is Predicted to be Worth US$143.2 mn by 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of
AIDS related Kaposi’s Sarcoma Market to Witness Steady Growth During the Forec …
AIDS-related Kaposi’s sarcoma is a type of cancer affecting the cells lining, the blood vessels, or lymph nodes. The cancer usually occurs as tumors on skin or mucosal surfaces. It is characterized by brown, red, or purple tumors on the affected area generally called as lesions. The major factors playing the role in the pathogenesis of the cancer are Kaposi’s sarcoma herpes virus/human herpes virus type 8 (KSHV/HHV-8), altered responses
New Report Examines the Growth of AIDS-related Kaposi’s Sarcoma Market Forecas …
AIDS-related Kaposi’s sarcoma is a type of cancer affecting the cells lining, the blood vessels, or lymph nodes. The cancer usually occurs as tumors on skin or mucosal surfaces. It is characterized by brown, red, or purple tumors on the affected area generally called as lesions. The major factors playing the role in the pathogenesis of the cancer are Kaposi’s sarcoma herpes virus/human herpes virus type 8 (KSHV/HHV-8), altered responses
US Cancer Vaccine Market Outlook 2020
Escalating cancer incidences have made the investigators to come forth with therapeutics that could reduce high morbidity and mortality rates. Cancer segment has several products belonging to different categories having different pharmacological efficacy. So, it becomes imperative for investigators to develop products that have both high pharmacological and commercialization potential. Numerous cancer therapeutic is available in market but they have limited pharmacological efficacy and high unmet medical necessities prevails across
AIDS-Related Kaposi’s Sarcoma Market – Global Industry Insights, Trends, An …
AIDS-related Kaposi’s sarcoma is a type of cancer affecting the cells lining, the blood vessels, or lymph nodes. The cancer usually occurs as tumors on skin or mucosal surfaces. It is characterized by brown, red, or purple tumors on the affected area generally called as lesions. The major factors playing the role in the pathogenesis of the cancer are Kaposi’s sarcoma herpes virus/human herpes virus type 8 (KSHV/HHV-8), altered responses
AIDS-related Kaposi’s Sarcoma Market Report 2017
AIDS-related Kaposi’s sarcoma is a type of cancer affecting the cells lining, the blood vessels, or lymph nodes. The cancer usually occurs as tumors on skin or mucosal surfaces. It is characterized by brown, red, or purple tumors on the affected area generally called as lesions. The major factors playing the role in the pathogenesis of the cancer are Kaposi’s sarcoma herpes virus/human herpes virus type 8 (KSHV/HHV-8), altered responses